Hypertension Patches Recalled

Teva Pharmaceuticals USA is recalling a single lot of clonidine transdermal patches for failing to meet impurities/degradation specifications, according to the November 24, 2021, US Food and Drug Administration (FDA) Enforcement Report.

The recall affects clonidine transdermal system, 0.1 mg/day, 4 patches per carton (NDC 0591-3508-04), from lot 1369117B (Exp. 11/21). The product was manufactured by Actavis Laboratories, Salt Lake City, UT, and distributed by Actavis Pharma, Inc., Parsippany, NJ, throughout the United States and in Puerto Rico.

Teva Pharmaceuticals voluntarily initiated the recall October 28, 2021. On November 16, 2021, the FDA designated the recall Class III. Under the recall classification, use of the affected patches is not likely to cause harm.

Clonidine transdermal system is a prescription medication used to treat high blood pressure.